Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03533465 · ClinicalTrials.gov registry record · NA
Understanding the Role of Sleep in Complicated Grief
A NA study, sponsored by NYU Langone Health.
- Terminated
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT03533465 is a NA study that was terminated before completion, run by NYU Langone Health. The registered enrollment target is 5 participants.
The verdict
NCT03533465, a NA study, was terminated before completion, sponsored by NYU Langone Health.
- TERMINATED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
The purpose of this study is to learn more about the causes of Complicated Grief (CG) in those who experience the loss of a loved one. This study aims at learning more about the sleep patterns and emotions in participants with CG as compared to those who have lost a loved one but do not have CG. This study will consist of two aims: Aim 1: Approximately 10 complicated grief (CG) patients and 10 controls (without a current psychiatric diagnosis) will complete a 3-day home polysomnography (PSG) sleep assessment in addition to several self-report sleep and psychiatric measures. Aim 2: Approximately 10 CG patients (subsample from Aim 1) will complete 16 weekly sessions of complicated grief therapy (CGT) in addition to completion of repeated PSG assessments and self-report sleep and psychiatric measures.
Interventions
- BEHAVIORAL Complicated Grief Therapy (CGT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2018-07-02 |
| Est. Completion | 2019-03-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03533465
The ClinicalTrials.gov registry entry for NCT03533465 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Complicated Grief Therapy (CGT) is the first listed.
NCT03533465 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03533465 about?
NCT03533465 is a clinical study titled "Understanding the Role of Sleep in Complicated Grief". The purpose of this study is to learn more about the causes of Complicated Grief (CG) in those who experience the loss of a loved one. This study aims at learning more about the sleep patterns and emotions in participants with CG as compared to those who have lost a loved one but do not have CG. Th...
What is the current status of trial NCT03533465?
This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 2018-07-02. Estimated completion is 2019-03-25.
What interventions are being tested in trial NCT03533465?
The interventions under investigation include: Complicated Grief Therapy (CGT) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03533465?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.